SecBot SecBot
8-K ·Filed Apr 23, 2026

CHE

CHEMED CORP
BULLISH
Impact 7/10
Horizonimmediate Processed6mo ago SEC0000019584-26-000010
8-K Item 2.02: Earnings release
Actionable Insight ▲ Bullish

The raised guidance driven by VITAS performance and share repurchases suggests strong underlying momentum; monitor VITAS admissions and Roto-Rooter's marketing costs for future trends.

DirectionBullish
Confidencehigh
Horizonimmediate

Price Chart

Loading chart...

Executive Summary

Chemed reported Q1 2026 earnings with revenue of $657.5M (1.6% YoY growth) and GAAP EPS of $4.84, a slight decrease YoY. Adjusted EPS increased 0.4% to $5.65. VITAS segment revenue grew 3.1% and admissions rose 6.9%, while Roto-Rooter revenue declined 0.9%. The company raised full-year 2026 EPS guidance to $24.00-$24.75, citing strong VITAS performance and share repurchases.

Key Financial Metrics

EPS
$5.65
est $5.63 · +0.4%
Revenue
$657.5M
est $649.8M · +1.2% · +1.6% YoY
Rating
beat

Key Facts

  • Q1 2026 revenue: $657.5M (1.6% YoY growth)
  • Q1 2026 GAAP EPS: $4.84 (0.4% decrease YoY)
  • Q1 2026 Adjusted EPS: $5.65 (0.4% increase YoY)
  • VITAS net revenue: $420.0M (3.1% YoY growth), admissions up 6.9%
  • Roto-Rooter revenue: $237.5M (0.9% decline YoY)
  • Company repurchased 500,000 shares for $197.7M in Q1
  • Full-year 2026 EPS guidance raised to $24.00-$24.75 (from $23.25-$24.25)

Financial Impact

Revenue growth of 1.6% and raised full-year EPS guidance

revenueepsguidance

Risk Factors

  • Roto-Rooter revenue declined 0.9% YoY
  • Roto-Rooter adjusted EBITDA margin declined 218 basis points
  • Elevated marketing costs expected to persist for Roto-Rooter

Market Snapshot

Exchange
NYSE
Sector
Services-Home Health Care Services
Analyst Consensus
50% bullish (8 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0000019584-26-000010
Document: che-20260423x8k.htm0000019584-26-000010
Document: 0000019584-26-000010-index-headers.html0000019584-26-000010
Document: 0000019584-26-000010-index.html0000019584-26-000010
Document: 0000019584-26-000010.txt0000019584-26-000010
8-K Data (Synthetic)0000019584-26-000010

Track record

19 reports on CHE

Performance horizon

2 of 3 bullish or bearish reports moved the stock their way by T+5. Best: +2.86% at T+5 after the Oct 27, 2026 report. 3 of 3 went positive at some point.

Filters
  1. Nov 6, 202610d ago Press Release Neutral 2/10 Entry $528.05 to $548.20 Now $549.45 +4.05% ▲ +3.82% +1.22% vs SPY
  2. Nov 5, 202611d ago Insider Cluster Bearish 4/10 Entry $533.77 to $550.20 Now $549.45 −2.94% ▼ −3.08% +0.21% vs SPY
  3. Nov 3, 202613d ago 144 Neutral 2/10 Entry $533.65 to $544.49 Now $549.45 +2.96% ▲ +2.03% +2.62% vs SPY
  4. Oct 27, 202620d ago Institutional Cluster Mixed 4/10 Entry $533.36 to $548.64 Now $549.45 +3.02% ▲ +2.86% +3.58% vs SPY
  5. Oct 27, 202620d ago 8-K Bullish 6/10 No price data
  6. Oct 27, 202620d ago Press Release Bullish 6/10 Entry $533.36 to $548.64 Now $549.45 +3.02% ▲ +2.86% +3.58% vs SPY
  7. Oct 23, 202624d ago Institutional Cluster Mixed 3/10 Entry $512.98 to $534.72 Now $549.45 +7.11% ▲ +4.24% +4.80% vs SPY
  8. Oct 1, 20266w ago Press Release Neutral 1/10 Entry $502.90 to $498.25 Now $549.45 +9.26% ▼ −0.92% −2.23% vs SPY
  9. Sep 16, 20268w ago Press Release Neutral 4/10 Entry $505.97 to $495.65 Now $549.45 +8.59% ▼ −2.04% −2.64% vs SPY
  10. Aug 24, 202612w ago Insider Cluster Neutral 3/10 Entry $541.34 to $518.71 Now $549.45 +1.50% ▼ −4.18% −4.65% vs SPY
Showing 10 of 19

US Market Status

Market Closed · Opens in 8h 19m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 23, 2026